Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Viracta Therapeutics (VIRX)
NASDAQ:VIRX
RESEARCH TOOLSreports
Holding VIRX?
Track your performance easily
| Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| EBIT | $ -8.28M | $ -12.84M | $ -11.65M | $ -11.59M | $ -12.12M |
| EBITDA | $ -8.17M | $ -11.13M | $ -11.52M | $ -12.01M | $ -12.52M |
| Net Income Common Stockholders | $ -9.14M | $ -13.58M | $ -12.60M | $ -12.48M | $ -12.12M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 39.57M | $ 53.69M | $ 62.95M | $ 72.87M | $ 80.33M |
| Total Assets | $ 41.33M | $ 56.69M | $ 66.44M | $ 76.86M | $ 85.66M |
| Total Debt | $ 18.86M | $ 25.56M | $ 25.56M | $ 25.55M | $ 25.54M |
| Net Debt | $ -20.71M | $ -28.14M | $ -37.39M | $ -47.31M | $ -54.79M |
| Total Liabilities | $ 30.25M | $ 38.37M | $ 36.43M | $ 36.08M | $ 34.67M |
| Stockholders Equity | $ 11.08M | $ 18.32M | $ 30.01M | $ 40.78M | $ 51.11M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -7.85M | $ -10.03M | $ -10.48M | $ -8.18M | $ -11.34M |
| Operating Cash Flow | $ -7.85M | $ -10.03M | $ -10.54M | $ -7.99M | $ -11.34M |
| Investing Cash Flow | $ 14.19M | $ 9.27M | $ 9.10M | $ 3.98M | $ -7.35M |
| Financing Cash Flow | $ -6.60M | $ 218.00K | - | $ 204.00K | $ 16.00K |